The aim of this study was to evaluate whether combined gene therapy with vascular endothelial growth factor (VEGF) plus apelin during indirect vasoreconstructive surgery enhances brain angiogenesis in a chronic cerebral hypoperfusion model in rats.
A chronic cerebral hypoperfusion model induced by the permanent ligation of bilateral common carotid arteries (CCAs; a procedure herein referred to as “CCA occlusion” [CCAO]) in rats was employed in this study. Seven days after the CCAO procedure, the authors performed encephalo-myo-synangiosis (EMS) and injected plasmid(s) into each rat's temporal muscle. Rats were divided into 4 groups based on which plasmid was received (i.e., LacZ group, VEGF group, apelin group, and VEGF+apelin group). Protein levels in the cortex and attached muscle were assessed with enzyme-linked immunosorbent assay (ELISA) on Day 7 after EMS, while immunofluorescent analysis of cortical vessels was performed on Day 14 after EMS.
The total number of blood vessels in the cortex on Day 14 after EMS was significantly larger in the VEGF group and the VEGF+apelin group than in the LacZ group (p < 0.05, respectively). Larger vessels appeared in the VEGF+apelin group than in the other groups (p < 0.05, respectively). Apelin protein on Day 7 after EMS was not detected in the cortex for any of the groups. In the attached muscle, apelin protein was detected only in the apelin group and the VEGF+apelin group. Immunofluorescent analysis revealed that apelin and its receptor, APJ, were expressed on endothelial cells (ECs) 7 days after the CCAO.
Combined gene therapy (VEGF plus apelin) during EMS in a chronic cerebral hypoperfusion model can enhance angiogenesis in rats. This treatment has the potential to be a feasible option in a clinical setting for patients with moyamoya disease.
INCLUDE WHEN CITING Published online December 23, 2016; DOI: 10.3171/2016.8.JNS16366.
Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
Anan M, Abe T, Matsuda T, Ishii K, Kamida T, Fujiki M, et al.: Induced angiogenesis under cerebral ischemia by cyclooxygenase 2 and hypoxia-inducible factor naked DNA in a rat indirect-bypass model. Neurosci Lett 409:118–123, 2006
Anan M, Abe T, Shimotaka K, Kamida T, Kubo T, Fujiki M, et al.: Induction of collateral circulation by hypoxia-inducible factor 1alpha decreased cerebral infarction in the rat. Neurol Res 31:917–922, 2009
Arsic N, Zentilin L, Zacchigna S, Santoro D, Stanta G, Salvi A, et al.: Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol Ther 7:450–459, 2003
Baumgartner I, Rauh G, Pieczek A, Wuensch D, Magner M, Kearney M, et al.: Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann Intern Med 132:880–884, 2000
Chae JK, Kim I, Lim ST, Chung MJ, Kim WH, Kim HG, et al.: Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 20:2573–2578, 2000
Dai T, Ramirez-Correa G, Gao WD: Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol 553:222–228, 2006
Eyries M, Siegfried G, Ciumas M, Montagne K, Agrapart M, Lebrin F, et al.: Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ Res 103:432–440, 2008
Farkas E, Luiten PG, Bari F: Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Brain Res Rev 54:162–180, 2007
Festa JR, Schwarz LR, Pliskin N, Cullum CM, Lacritz L, Charbel FT, et al.: Neurocognitive dysfunction in adult moyamoya disease. J Neurol 257:806–815, 2010
Gavard J, Gutkind JS: VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8:1223–1234, 2006
Harrigan MR, Ennis SR, Masada T, Keep RF: Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema. Neurosurgery 50:589–598, 2002
Hecht N, Marushima A, Nieminen M, Kremenetskaia I, von Degenfeld G, Woitzik J, et al.: Myoblast-mediated gene therapy improves functional collateralization in chronic cerebral hypoperfusion. Stroke 46:203–211, 2015
Karzmark P, Zeifert PD, Tan S, Dorfman LJ, Bell-Stephens TE, Steinberg GK: Effect of moyamoya disease on neuropsychological functioning in adults. Neurosurgery 62:1048–1052, 2008
Kasai A, Shintani N, Oda M, Kakuda M, Hashimoto H, Matsuda T, et al.: Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 325:395–400, 2004
Katsumata A, Sugiu K, Tokunaga K, Kusaka N, Watanabe K, Nishida A, et al.: Optimal dose of plasmid vascular endothelial growth factor for enhancement of angiogenesis in the rat brain ischemia model. Neurol Med Chir (Tokyo) 50:449–455, 2010
Kevil CG, Payne DK, Mire E, Alexander JS: Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J Biol Chem 273:15099–15103, 1998
Kidoya H, Naito H, Takakura N: Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. Blood 115:3166–3174, 2010
Kidoya H, Ueno M, Yamada Y, Mochizuki N, Nakata M, Yano T, et al.: Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J 27:522–534, 2008
Kim HS, Lee HJ, Yeu IS, Yi JS, Yang JH, Lee IW: The neovascularization effect of bone marrow stromal cells in temporal muscle after encephalomyosynangiosis in chronic cerebral ischemic rats. J Korean Neurosurg Soc 44:249–255, 2008
Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, et al.: Pediatric moyamoya disease: An analysis of 410 consecutive cases. Ann Neurol 68:92–101, 2010
Kuroda S, Houkin K: Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7:1056–1066, 2008
Kusaka N, Sugiu K, Tokunaga K, Katsumata A, Nishida A, Namba K, et al.: Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery. J Neurosurg 103:882–890, 2005
Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, et al.: Characterization of apelin, the ligand for the APJ receptor. J Neurochem 74:34–41, 2000
Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM: VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102:898–901, 2000
Lee SB, Kim DS, Huh PW, Yoo DS, Lee TG, Cho KS: Long-term follow-up results in 142 adult patients with moyamoya disease according to management modality. Acta Neurochir (Wien) 154:1179–1187, 2012
Masri B, Morin N, Cornu M, Knibiehler B, Audigier Y: Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J 18:1909–1911, 2004
Mizoi K, Kayama T, Yoshimoto T, Nagamine Y: Indirect revascularization for moyamoya disease: is there a beneficial effect for adult patients?. Surg Neurol 45:541–549, 1996
Nakamura M, Imai H, Konno K, Kubota C, Seki K, Puentes S, et al.: Experimental investigation of encephalomyosynangiosis using gyrencephalic brain of the miniature pig: histopathological evaluation of dynamic reconstruction of vessels for functional anastomosis. Laboratory investigation. J Neurosurg Pediatr 3:488–495, 2009
O'Carroll AM, Selby TL, Palkovits M, Lolait SJ: Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta 1492:72–80, 2000
O'Donnell LA, Agrawal A, Sabnekar P, Dichter MA, Lynch DR, Kolson DL: Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury. J Neurochem 102:1905–1917, 2007
Ohmori Y, Morioka M, Kaku Y, Kawano T, Kuratsu J: Granulocyte colony-stimulating factor enhances the angiogenetic effect of indirect bypass surgery for chronic cerebral hypoperfusion in a rat model. Neurosurgery 68:1372–1379, 2011
Pandey P, Steinberg GK: Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article. J Neurosurg 115:328–336, 2011
Park YS, Jeon YJ, Kim HS, Chae KY, Oh SH, Han IB, et al.: The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization. PLoS One 7:e47158, 2012
Samuel SM, Akita Y, Paul D, Thirunavukkarasu M, Zhan L, Sudhakaran PR, et al.: Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats. Diabetes 59:51–60, 2010
Schwarz ER, Speakman MT, Patterson M, Hale SS, Isner JM, Kedes LH, et al.: Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat—angiogenesis and angioma formation. J Am Coll Cardiol 35:1323–1330, 2000
Takakura N, Kidoya H: Maturation of blood vessels by haematopoietic stem cells and progenitor cells: involvement of apelin/APJ and angiopoietin/Tie2 interactions in vessel caliber size regulation. Thromb Haemost 101:999–1005, 2009
Tanaka K, Ogawa N, Asanuma M, Kondo Y, Nomura M: Relationship between cholinergic dysfunction and discrimination learning disabilities in Wistar rats following chronic cerebral hypoperfusion. Brain Res 729:55–65, 1996
Tashiro H, Aoki M, Isobe M, Hashiya N, Makino H, Kaneda Y, et al.: Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes. J Mol Cell Cardiol 39:503–509, 2005
Touho H, Karasawa J, Ohnishi H, Yamada K, Shibamoto K: Surgical reconstruction of failed indirect anastomosis in childhood Moyamoya disease. Neurosurgery 32:935–940, 1993
Toyama K, Honmou O, Harada K, Suzuki J, Houkin K, Hamada H, et al.: Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp Neurol 216:47–55, 2009
Yamauchi A, Ito Y, Morikawa M, Kobune M, Huang J, Sasaki K, et al.: Pre-administration of angiopoietin-1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model. J Gene Med 5:994–1004, 2003
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 274 | 70 | 28 |
| Full Text Views | 1075 | 110 | 3 |
| PDF Downloads | 1010 | 108 | 5 |
| EPUB Downloads | 0 | 0 | 0 |